Search

everythinglearnresearchcommunity

for

Search:↓

The serum with microneedling effectively treats alopecia areata by enhancing drug delivery and is safe and patient-friendly.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

Tofacitinib treatment for hair loss may worsen acne.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Intralesional methotrexate effectively treats alopecia areata by reducing TNF-α levels, leading to hair regrowth.

Upadacitinib effectively treats psoriasis and lichen planus together.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Infliximab may cause hair loss in Crohn's disease patients.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Acitretin is effective for certain types of psoriasis, safe for long-term use, and often combined with other treatments.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Adalimumab improved folliculitis decalvans in most patients.

ITK inhibitors may effectively treat alopecia areata.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Scalp condition healed with prednisone and tacrolimus.